A role for cancer stem cells in drug resistance and metastasis in non-small-cell lung cancer

Clinical and Translational Oncology

Volumn 13, Issue 5, 2011, Pages 289-293

  Perona, Rosario ^a   López Ayllón, Blanca D ^a   De Castro Carpeño, Javier ^b   Belda Iniesta, Cristóbal ^b  

^a INSTITUTO DE INVESTIGACIONES BIOMÉDICAS ALBERTO SOLS   (Spain)

^b HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

Author keywords

Cancer stem cells; Chemotherapy; Metastasis; Non small cell lung cancer

Indexed keywords

ALDEHYDE DEHYDROGENASE; CD133 ANTIGEN; CD34 ANTIGEN; CISPLATIN; HERMES ANTIGEN; IMATINIB; MICRORNA; OCTAMER TRANSCRIPTION FACTOR 4; STEM CELL FACTOR; TOBACCO SMOKE; TRANSCRIPTION FACTOR RUNX3; TRANSCRIPTION FACTOR SOX2;

ARTICLE; CANCER INVASION; CANCER RESISTANCE; CANCER STEM CELL; CANCER SURVIVAL; CARCINOGENICITY; CELL PROLIFERATION; CELL RENEWAL; CELL SURFACE; EPITHELIAL MESENCHYMAL TRANSITION; HUMAN; LUNG CARCINOGENESIS; LUNG NON SMALL CELL CANCER; METASTASIS; NONHUMAN; PROGNOSIS; PROGRESSION FREE SURVIVAL; SELF RENEWAL; SIDE POPULATION CELL; SIGNAL TRANSDUCTION;

ALDEHYDE DEHYDROGENASE; ANTIGENS, CD; ANTIGENS, CD34; ANTIGENS, CD44; CARCINOMA, NON-SMALL-CELL LUNG; CELL DIFFERENTIATION; DRUG RESISTANCE, NEOPLASM; GLYCOPROTEINS; HUMANS; LUNG NEOPLASMS; MEDICAL ONCOLOGY; NEOPLASM METASTASIS; NEOPLASTIC STEM CELLS; PEPTIDES; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; TREATMENT OUTCOME;

EID: 79960685139     PISSN: 1699048X     EISSN: 16993055     Source Type: Journal    
DOI: 10.1007/s12094-011-0656-3     Document Type: Article

References (48)

1. Dick JE (1994) Future prospects for animal models created by transplanting human haematopoietic cells into immune-defi cient mice. Res Immunol 145:380-384. Review (Pubitemid 24371734)
2. Singh SK, Hawkins C, Clarke ID et al (2004) Identifi cation of human brain tumour initiating cells. Nature 432:396-401 (Pubitemid 39551674)
3. Ponti D, Costa A, Zaffaroni N et al (2005) Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties. Cancer Res 65:5506-5511 (Pubitemid 40911148)
4. Patrawala L, Calhoun T, Schneider-Broussard R et al (2006) Highly purifi ed CD44+ prostate cancer cells from xenograft human tumors are enriched in tumorigenic and metastatic progenitor cells. Oncogene 25:1696-1708
5. Ricci-Vitiani L, Lombardi DG, Pilozzi E et al (2007) Identification and expansion of human colon-cancer-initiating cells. Nature 445:111-115 (Pubitemid 46067311)
6. Li C, Heidt DG, Dalerba P et al (2007) Identifi cation of pancreatic cancer stem cells. Cancer Res 67:1030-1037
7. Minna JD, Roth JA, Gazdar AF (2001) Focus on lung cancer. Cancer Cell 1:49-52 (Pubitemid 41039175)
8. Eramo A, Lotti F, Sette G et al (2008) Identifi-cation and expansion of the tumorigenic lung cancer stem cell population. Cell Death Differ 15:504-514 (Pubitemid 351267301)
9. Giangreco A, Groot KR, Janes SM (2007) Lung cancer and lung stem cells: strange bedfellows? Am J Respir Crit Care Med 175:547-553 (Pubitemid 46438936)
10. Tiseo M, Bartolotti M, Gelsomino F, Ardizzoni A (2009) First-line treatment in advanced non-small-cell lung cancer: the emerging role of the histologic subtype. Expert Rev Anticancer Ther 9:425-435
11. Bianchi F, Nicassio F, Di Fiore PP (2008) Unbiased vs. biased approaches to the identification of cancer signatures: the case of lung cancer. Cell Cycle 7:729-734 (Pubitemid 351520034)
12. Scagliotti GV, De Marinis F, Rinaldi M et al (2009) The role of histology with common fi rstline regimens for advanced non-small cell lung cancer: a brief report of the retrospective analysis of a three-arm randomized trial. J Thorac Oncol 4:1568-1571
13. Lanza F, Healy L, Sutherland DR (2001) Structural and functional features of the CD34 antigen: an update. J Biol Regul Homeost Agents 15:1-13 (Pubitemid 32492723)
14. Ryan DH, Chapple CW, Kossover SA et al (1987) Phenotypic similarities and differences between CALLA-positive acute lymphoblastic leukemia cells and normal marrow CALLA-positive B cell precursors. Blood 70:814-821 (Pubitemid 18027417)
15. Kitamura H, Okudela K, Yazawa T et al (2009) Cancer stem cell: implications in cancer biology and therapy with special reference to lung cancer. Lung Cancer 66:275-281
16. Shmelkov SV, St Clair R, Lyden D et al (2005) AC133/CD133/Prominin-1. Int J Biochem Cell Biol 37:715-719 (Pubitemid 40202993)
17. Uchida N, Buck DW, He D et al (2000) Direct isolation of human central nervous system stem cells. Proc Natl Acad Sci U S A 97:14720-14725 (Pubitemid 32016642)
18. Salven P, Mustjoki S, Alitalo R et al (2003) VEGFR-3 and CD133 identify a population of CD34+ lymphatic/vascular endothelial precursor cells. Blood 101:168-172 (Pubitemid 36025904)
19. Richardson GD, Robson CN, Lang SH et al (2004) CD133, a novel marker for human prostatic epithelial stem cells. J Cell Sci 117:3539-3545 (Pubitemid 39206394)
20. Piechaczek C (2001) CD133. J Biol Regul Homeost Agents 15:101-102 (Pubitemid 32492736)
21. Wang J, Sakariassen Pø, Tsinkalovsky O et al (2008) CD133 negative glioma cells form tumors in nude rats and give rise to CD133 positive cells. Int J Cancer 122:761-768
22. Ogden AT, Waziri AE, Lochhead RA et al (2008) Identification of A2B5+CD133-tumor-initiating cells in adult human gliomas. Neurosurgery 62:505-514 (Pubitemid 351489297)
23. Shmelkov SV, Butler JM, Hooper AT et al (2008) CD133 expression is not restricted to stem cells, and both CD133+ and CD133-metastatic colon cancer cells initiate tumors. J Clin Invest 20118:2111-2120 (Pubitemid 351872330)
24. Wu C, Alman BA (2008) Side population cells in human cancers. Cancer Lett 268:1-9
25. Zhou S, Schuetz JD, Bunting KD et al (2001) The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype. Nat Med 7:1028-1034 (Pubitemid 32937383)
26. Sophos NA, Vasiliou V (2003) Aldehyde dehydrogenase gene superfamily: the 2002 update. Chem Biol Interact 143-144:5-22 (Pubitemid 36253575)
27. Clarke MF, Dick JE, Dirks PB et al (2006) Cancer stem cells-perspectives on current status and future directions: AACR Workshop on cancer stem cells. Cancer Res 66:9339-9344 (Pubitemid 44623625)
28. Ho MM, Ng AV, Lam S, Hung JY (2007) Side population in human lung cancer cell lines and tumors is enriched with stem-like cancer cells. Cancer Res 67:4827-4833 (Pubitemid 46910191)
29. Levina V, Marrangoni AM, DeMarco R et al (2008) Drug-selected human lung cancer stem cells: cytokine network, tumorigenic and metastatic properties. PLoS One 3:3077
30. Jiang F, Qiu Q, Khanna A et al (2009) Aldehyde dehydrogenase 1 is a tumor stem cell-associated marker in lung cancer. Mol Cancer Res 7:330-338
31. Stuelten CH, Mertins SD, Busch JI et al (2010) Complex display of putative tumor stem cell markers in the NCI60 tumor cell line panel. Stem Cells 28:649-660
32. Eramo A, Lotti F, Sette G et al (2008) Identification and expansion of the tumorigenic lung cancer stem cell population. Cell Death Differ 15:504-514 (Pubitemid 351267301)
33. Bertolini G, Roz L, Perego P et al (2009) Highly tumorigenic lung cancer CD133+ cells display stem-like features and are spared by cisplatin treatment. Proc Natl Acad Sci U S A 106:16281-16286
34. Sullivan JP, Spinola M, Dodge M et al (2010) Aldehyde dehydrogenase activity selects for lung adenocarcinoma stem cells dependent on notch signaling. Cancer Res 70:9937-9948
35. Akunuru S, Palumbo J, Zhai QJ et al (2011) Rac1 targeting suppresses human non-small cell lung adenocarcinoma cancer stem cell activity. PLoS One 6:e16951
36. Lee KS, Lee YS, Lee JM et al (2010) Runx3 is required for the differentiation of lung epithelial cells and suppression of lung cancer. Oncogene 29:3349-3361
37. Boyer LA, Lee TI, Cole MF et al (2005) Core transcriptional regulatory circuitry in human embryonic stem cells. Cell 122:947-956 (Pubitemid 41345211)
38. Ivanova N, Dobrin R, Lu R et al (2006) Dissecting self-renewal in stem cells with RNA interference. Nature 442:533-538 (Pubitemid 44167907)
39. Hussenet T, Dali S, Exinger J et al (2010) SOX2 is an oncogene activated by recurrent 3q26.3 amplifi cations in human lung squamous cell carcinomas. PLoS One 5:8960
40. Ge N, Lin HX, Xiao XS et al (2010) Prognostic signifi cance of Oct4 and Sox2 expression in hypopharyngeal squamous cell carcinoma. J Transl Med 8:94
41. Hu T, Liu S, Breiter DR et al (2008) Octamer 4 small interfering RNA results in cancer stem celllike cell apoptosis. Cancer Res 68:6533-6540
42. Hassan HT (2009) c-Kit expression in human normal and malignant stem cells prognostic and therapeutic implications. Leuk Res 33:5-10
43. Levina V, Marrangoni A, Wang T et al (2010) Elimination of human lung cancer stem cells through targeting of the stem cell factor-c-kit autocrine signaling loop. Cancer Res 70:338-346
44. Guarino M, Rubino B, Ballabio G (2007) The role of epithelial-mesenchymal transition in cancer pathology. Pathology 39:305-318 (Pubitemid 46897605)
45. Gregory PA, Bert AG, Paterson EL et al (2008) The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol 10:593-601 (Pubitemid 351627379)
46. Park SM, Gaur AB, Lengyel E et al (2008) The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2. Genes Dev 22:894-907 (Pubitemid 351482843)
47. Tellez CS, Juri DE, Do K et al (2011) EMT and stem cell-like properties associated with miR-205 and miR-200 epigenetic silencing are early manifestations during carcinogen-induced transformation of human lung epithelial cells. Cancer Res 71:3087-3097
48. Leung EL, Fiscus RR, Tung JW et al (2010) Nonsmall cell lung cancer cells expressing CD44 are enriched for stem cell-like properties. PLoS One 5:e14062